- Increased interest in Leclanché’s cell technology since the announcement of PFAS-free electrodes
- Delivery of entirely PFAS free cells to key partners for validation to take place in the next weeks
- Increased demand for next generation niobium oxide anode lithium-ion cells
Amid growing concerns surrounding the impacts of PFAS, which stands for per- and polyfluoroalkyl substances, a chemical widely used in the production of lithium-ion batteries, Europe is setting out plans to restrict its usage. With many suppliers in the battery industry set to be heavily affected by the plans, Leclanché SA, which has been using a water-based binder process in its cell production for over 13 years, is prepared for these new restrictions.
The Swiss company is attracting strong interest from a number of industrial players, including automotive OEMs, in the water-based electrode manufacturing and PFAS free technology. Leclanché will be supplying lithium-ion cells which are entirely PFAS free to a number of partners, with the first samples planned to be delivered in the coming weeks.
In addition to the traditional graphite-based anode cells for high energy density applications, Leclanché has developed cells using the same water-based manufacturing process but with niobium oxide electrodes. These cells show a lot of promise for high performance and fast charge capabilities. A growing number of clients and partners are now approaching Leclanché for the testing of these cells.
The recognition by the market of PFAS free electrode technology and its ability to address both energy and power applications, is a key milestone in the current regulatory environment.
PFAS comprises a combination of man-made chemicals that have been extensively incorporated into a wide variety of industrial and consumer products since the 1950s. However, concerns surrounding PFAS have gained significant traction since the early 2000s due to their prolonged persistence in the environment and the potential adverse impacts on human health. Exposure to PFAS has been associated with a range of health issues including cancer, immune system dysfunction, reproductive health and developmental disorders. Consequently, a substantial shift is underway to eliminate their usage.
